Objective:
To discuss the integration and optimization of minimally invasive glaucoma surgery (MIGS) in ambulatory surgical centers (ASCs).
Approach:
- MIGS Implementation: MIGS is positioned as a core capability in ASCs, enhancing clinical outcomes, patient experience, and ASC economics.
- Operational Efficiency: Focus on execution, understanding the clinical landscape, controlling device costs, and optimizing intraoperative workflow.
- Scheduling and Training: Implement tiered scheduling and ensure team training to minimize operational disruptions.
Key Findings:
- MIGS can be performed alongside cataract surgery with minimal additional time and resource burden.
- The incorporation of MIGS can enhance OR throughput and profitability in ASCs.
- Different MIGS mechanisms have varying operational demands and cost profiles.
Interpretation:
MIGS is a viable and efficient addition to ASC offerings, addressing the glaucoma burden while maintaining operational efficiency.
Limitations:
- Challenges with device visualization and procedural complications may arise.
- Careful patient counseling regarding potential side effects of sustained-release drug delivery systems is necessary.
Conclusion:
MIGS represents an advancement in glaucoma treatment within ASCs.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.